Results 171 to 180 of about 106,180 (310)

Esofagitis eosinofilíca ¿otra forma clínica de polinosis? [PDF]

, 2017
La esofagitis eosinofílica es una enfermedad emergente en nuestro medio, en la que se produce una inflamación inmunoalérgica crónica a nivel del esófago, que ocasiona una disfunción esofágica y se caracteriza por un infiltrado de eosinófilos a nivel del ...
Calvo Gómez, David
core  

Characteristics and Clinical Management of Eosinophilic Esophagitis in Australia: A National Survey

Clinical &Experimental Allergy, EarlyView.
A. Clancy, A. Swain, E. Beck, V. Soutter, R. Loblay   +4 more
wiley   +1 more source

The conundrum of esophagogastric junction outflow obstruction: Answers to key clinical questions

Annals of the New York Academy of Sciences, EarlyView.
Esophagogastric junction outflow obstruction (EGJOO) is a heterogeneous disorder characterized by abnormal esophagogastric junction pressures in the setting of intact peristalsis. The significance of this finding is highest in patients with dysphagia or chest pain, and in patients for whom there is a clinical suspicion for an achalasia variant.
Kristle Lee Lynch, C. Prakash Gyawali, Enrique Coss‐Adame, Stefano Siboni, Christopher Vélez, Abraham Khan, Pierfrancesco Visaggi, Joshua A. Sloan, Sravanya Gavini, Marco Sozzi, Justin Wu   +10 more
wiley   +1 more source

Impacto Alimentar Esofágico, um Dilema Diagnóstico [PDF]

, 2017
O impacto alimentar esofágico é uma situação que na maioria dos casos é secundária a patologia esofágica congénita ou adquirida, podendo constituir a primeira manifestação da doença.
Cabral, J, Cunha, F, Furtado, F, Oliveira, L, Queirós, G, Rúbio, C   +5 more
core  

A pilot study on anti‐reflux mucoplasty with valve as novel endoscopic therapy for gastroesophageal reflux disease

DEN Open, Volume 6, Issue 1, April 2026.
Abstract Background and aims Endoscopic anti‐reflux therapies like anti‐reflux mucosectomy (ARMS) and anti‐reflux mucosal ablation have shown efficacy for gastroesophageal reflux disease (GERD) in systematic reviews and meta‐analyses. Anti‐reflux mucoplasty (ARM‐P), a refinement of ARMS, incorporates immediate closure of the resection site to reduce ...
Kazuki Yamamoto, Haruhiro Inoue, Ippei Tanaka, Rei Miyake, Masachika Saino, Kei Ushikubo, Miyuki Iwasaki, Yohei Nishikawa, Satoshi Abiko, Boldbaatar Gantuya, Manabu Onimaru, Mayo Tanabe   +11 more
wiley   +1 more source

Translation and cultural adaptation of the Pediatric Eosinophilic Esophagitis Symptom Score (PEESS v2.0)

Jornal de Pediatria (Versão em Português), 2018
Objectives: To translate and culturally adapt the Pediatric Eosinophilic Esophagitis Symptom Score (version 2.0), a tool used to assess pediatric eosinophilic esophagitis symptoms reported by patients and/or their parents/caregivers.
Maria Fernanda Oliveira Santos, Cristina Palmer Barros, Carlos Henrique Martins da Silva, Helena Borges Martins da Silva Paro   +3 more
doaj   +2 more sources

A Case Report of Eosinophilic Esophagitis with Dysphagia

Xiehe Yixue Zazhi
This paper reports a case of eosinophilic esophagitis who presented with dysphagia. The patient was a 54-year-old woman with diffuse esophageal thickening on ultrasonographic gastroscopy.
WANG Yanan, ZHAO Xinlu, XU Guifang
doaj   +1 more source

Visibility Evaluation of Fundic Gland Polyp Associated With Proton Pump Inhibitor in Texture and Color Enhancement Imaging

DEN Open, Volume 6, Issue 1, April 2026.
ABSTRACT Objectives A ‘gray color sign’ (GCS) is a new endoscopic feature of fundic gland polyp associated with proton pump inhibitor (PPI‐FGP). Here, we compare the ability of texture and color enhancement imaging (TXI) to white light imaging (WLI) with regard to the detection of GCS. Methods In this prospective study, 19 consecutive patients with PPI‐
Ryota Uchida, Hiroya Ueyama, Tsutomu Takeda, Shunsuke Nakamura, Yasuko Uemura, Tomoyo Iwano, Momoko Yamamoto, Hisanori Utsunomiya, Daiki Abe, Shotaro Oki, Nobuyuki Suzuki, Atsushi Ikeda, Yoichi Akazawa, Kumiko Ueda, Mariko Hojo, Shuko Nojiri, Takashi Yao, Akihito Nagahara   +17 more
wiley   +1 more source

Clinical Characteristics and Outcomes of Incomplete Cardia Reconstruction Cases Following Multiple Anti‐reflux Mucosectomy/Anti‐reflux Mucosal Ablation Treatments

DEN Open, Volume 6, Issue 1, April 2026.
ABSTRACT Introduction Anti‐reflux mucosectomy (ARMS) and anti‐reflux mucosal ablation (ARMA) are novel endoscopic treatments for proton pump inhibitor or potassium‐competitive acid blocker‐refractory gastroesophageal reflux disease. These procedures induce scarring of the artificial ulcer at the gastric cardia, which tightens the enlarged cardiac ...
Ippei Tanaka, Haruhiro Inoue, Mayo Tanabe, Yoshiaki Kimoto, Kei Ushikubo, Kazuki Yamamoto, Yohei Nishikawa, Nikko Theodore Valencia Raymundo, Kazuya Sumi   +8 more
wiley   +1 more source

First‐in‐Human Phase 1 Study to Evaluate the Clinical Pharmacology Properties of RBN‐3143, a Novel Inhibitor of Mono‐Adenosine Diphosphate Ribosyltransferase‐PARP14

Clinical Pharmacology in Drug Development, Volume 14, Issue 7, Page 493-504, July 2025.
Abstract RBN‐3143 is an inhibitor of PARP14 in development for inflammatory diseases. Multiple assessments were conducted to evaluate the clinical pharmacology properties of RBN‐3134. A randomized, double‐blind, placebo‐controlled study assigned healthy volunteers (HVs) to single ascending doses (SADs) (25‐1000 mg) or multiple ascending doses (MADs ...
Thomas M. Polasek, Alexandra Cole, Viviana Bozón, Erika Manyak, Jonathan Novak, Barbara Yang, Briohny A. Johnston, Sudha Parasuraman, Kushal J. Paneliya, Virna Schuck   +9 more
wiley   +1 more source